FDA NDC Directory · JSON-LD · Markdown

BUPIVACAINE HCl

NDC 51662-1592 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryNew Drug Application (innovator) · App NDA018304
Dosage form / routeINJECTION, SOLUTION · INFILTRATION PERINEURAL
Active ingredientsBUPIVACAINE HYDROCHLORIDE (2.5 mg/mL)
Marketing started20220713
Package count1

External sources

Source: openFDA. Public-domain (CC0).